Skip to main content
Log in

Use of Prior Information to Stabilize a Population Data Analysis

  • Published:
Journal of Pharmacokinetics and Pharmacodynamics Aims and scope Submit manuscript

Abstract

When modeling new data with a complex population pharmacokinetic/pharmacodynamic model, there may not be sufficient information to obtain estimates of all parameters. In this case information from previous studies can also be used to help stabilize estimation. Using simulated data, we explored three different ways to do this. (i) Some parameter values were fixed to estimates obtained from earlier data. (ii) The earlier data were combined with the current data. (iii) The objective function based on the current data was augmented by a penalty function expressing summary information obtained from the earlier data. This last method is similar to the use of a Bayesian prior. It may be particularly useful when either the combined data set of method (ii) is very large and leads to large computation times or when the early data are not readily available. With this method, two different types of penalty functions were used. With our examples, the three methods all resulted in stabilized estimation. Methods (ii) and (iii) gave similar results for parameter and standard error estimation, especially with respect to fixed effects parameters. For hypothesis testing, results obtained with method (i) are very problematic. There are also problems with the results obtained with method (iii), but they are much less severe, and when the design for the earlier data is known, they can be corrected by using a computer-intensive simulation test procedure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. L. Yuh, S. L. Beal, M. Davidian, F. Harrison, A. Hestor, K. Kowalski, E. Vonesh, and R. Wolfinger. Population pharmacokinetic/pharmacodynamic methodology and applications: A bibliography. Biometrics 50:566–575 (1994).

    PubMed  Google Scholar 

  2. J. R. Wade, S. L. Beal, and N. C. Sambol. Interaction between structural, statistical, and covariate models in population pharmacokinetic analysis. J. Pharmacokin. Biopharmaceutics 22:165–177 (1994).

    Google Scholar 

  3. J. R. Wade, A. W. Kelman, C. A. Howie, and B. Whiting. Effect of misspecification of the absorption process on subsequent parameter estimation in population analysis. J. Pharmacokin. Biopharm. 21:209–222 (1993).

    Google Scholar 

  4. R. Bruno, N. Vivier, J. C. Vergniol, S. L. D. Phillips, G. Montay, and L. B. Sheiner. A population pharmacokinetic model for docetaxel (taxotere): Model building and validation. J. Pharmacokin. Biopharm. 24:153–712 (1996).

    Google Scholar 

  5. L. E. Simonsen, U. Wahlby, M. Sandstrom, A. Freijs, and M. O. Karlsson. Haematological toxicity following different dosing schedules of 5-fluorouacil and epirubicin in rats. Anticancer Research 20:1519–1525 (2000).

    PubMed  Google Scholar 

  6. S. L. Beal and L. B. Sheiner. Methodology of population pharmacokinetics. In E. R. Garrett and J. L. Hirtz (eds.), Drug Fate and Metabolism: Methods and Techniques, vol. 5, Marcel Decker, New York, 1985, pp. 135–183.

    Google Scholar 

  7. T. M. Ludden, S. R. B. Allerheiligen, and R. F. Bank. Application of population analysis to physiological pharmacokinetics. J. Pharmacokin. Biopharm. 19:101S-113S (1991).

    Google Scholar 

  8. A. Gelman, F. Bois, and J. Jiang. Physiological pharmacokinetic analysis using population modeling and informative prior distributions. J. Am. Stat. Assn. 91:1400–1412 (1996).

    Google Scholar 

  9. S. L. Beal and L. B. Sheiner. NONMEM Users Guides (I-VIII). Hanover, Maryland: GloboMax, 1989–1998.

    Google Scholar 

  10. S. L. Beal and L. B. Sheiner. NONMEM Users Guide-Part VII: Conditional Estimation Methods. Hanover, Maryland: GloboMax, 1992–1998.

    Google Scholar 

  11. N. L. Johnson and S. Kotz. Distributions in Statistics: Continuous Multiûariate Distributions. John Wiley and Sons, New York, 1972.

    Google Scholar 

  12. J. Wakefield. The Bayesian analysis of population pharmacokinetic models. J. of the American Statistical Association 91:62–75 (1996).

    Google Scholar 

  13. G. E. P. Box and G. C. Tiao. Bayesian Inference in Statistical Analysis. Addison-Wesley, New York, 1973.

    Google Scholar 

  14. J. C. Wakefield, A. F. M. Smith, A. Racine-Poon, and A. E. Gelfand. Bayesian analysis of linear and nonlinear population models using the Gibbs sampler. Appl. Stat. 43:201–222 (1994).

    Google Scholar 

  15. D. R. Cox and D. V. Hinkley. Theoretical Statistics. Chapman and Hall, London, 1974.

    Google Scholar 

  16. U. Wahlby, E. N. Jonsson, and M. O. Karlsson. Assessment of significance Levels for covariate effects in NONMEM. J. Pharmacokin. Pharmacodyn. 28:231–252 (2001).

    Google Scholar 

  17. S. L. Beal. Commentary on significance levels for covariate effects in NONMEM. J. Pharmacokin. Pharmacodyn. 29:403–410 (2002).

    Google Scholar 

  18. Y. Yano, S. L. Beal, and L. B. Sheiner. Evaluating pharmacokinetic_pharmacodynamic models using the posterior predictive check. J. Pharmacokin. Pharmacodyn.28:171–192 (2001).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gisleskog, P.O., Karlsson, M.O. & Beal, S.L. Use of Prior Information to Stabilize a Population Data Analysis. J Pharmacokinet Pharmacodyn 29, 473–505 (2002). https://doi.org/10.1023/A:1022972420004

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1022972420004

Navigation